Bioequivalence of Imeglimin Tablet Formulations
Clinical trial NCT03646331 · COMPLETED
Trial details
- NCT number
- NCT03646331
- Sponsor
- Poxel SA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-03
- Primary completion
- 2018-09-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.